15951552

Source:http://linkedlifedata.com/resource/pubmed/id/15951552

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0009429, umls-concept:C0018951, umls-concept:C0040808, umls-concept:C0087111, umls-concept:C0301625, umls-concept:C0524910, umls-concept:C0556895, umls-concept:C1551432
pubmed:issue	7
pubmed:dateCreated	2005-6-13
pubmed:abstractText	Treatment of chronic hepatitis C with interferon (IFN)-alpha and ribavirin has haematotoxic effects. We evaluated the effects of four different IFN/IFN-ribavirin treatment regimens on haematopoiesis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10648388, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10733558, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10779449, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10803930, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10898329, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-10979953, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11084083, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11244158, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11434597, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11474308, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11583749, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-11679972, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-12105843, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-12324553, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-12395340, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-12407599, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-12761728, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-14638354, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-1590332, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-1865526, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-1959884, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-3115335, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-323135, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-6711573, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-7535585, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-7610660, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-7611214, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-7739682, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8630374, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8682483, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8785018, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8834023, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8938167, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-8938532, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9011789, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9024300, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9252161, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9794931, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9819446, http://linkedlifedata.com/resource/pubmed/commentcorrection/15951552-9819447
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0017-5749
pubmed:author	pubmed-author:DaunVV, pubmed-author:FerenczAA, pubmed-author:GanglAA, pubmed-author:HomoncikMM, pubmed-author:JessnerWW, pubmed-author:KreisHH, pubmed-author:Peck-RadosavljevicMM, pubmed-author:SchmidMM
pubmed:issnType	Print
pubmed:volume	54
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1014-20
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:15951552-Adult, pubmed-meshheading:15951552-Aged, pubmed-meshheading:15951552-Antiviral Agents, pubmed-meshheading:15951552-Drug Therapy, Combination, pubmed-meshheading:15951552-Erythropoiesis, pubmed-meshheading:15951552-Female, pubmed-meshheading:15951552-Hematopoiesis, pubmed-meshheading:15951552-Hepatitis C, Chronic, pubmed-meshheading:15951552-Humans, pubmed-meshheading:15951552-Interferon-alpha, pubmed-meshheading:15951552-Leukocyte Count, pubmed-meshheading:15951552-Male, pubmed-meshheading:15951552-Middle Aged, pubmed-meshheading:15951552-Prospective Studies, pubmed-meshheading:15951552-Recombinant Proteins, pubmed-meshheading:15951552-Ribavirin, pubmed-meshheading:15951552-Thrombopoiesis
pubmed:year	2005
pubmed:articleTitle	Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens.
pubmed:affiliation	Department of Internal Medicine IV, Division of Gastroenterology and Hepatology, University of Vienna, Währingergürtel 18-20, A-1090 Vienna, Austria.
pubmed:publicationType	Journal Article